Status:
COMPLETED
Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy
Lead Sponsor:
Sanquin Research & Blood Bank Divisions
Collaborating Sponsors:
Maastricht University Medical Center
Atrium Medical Center
Conditions:
Hemochromatosis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
In this project we plan to evaluate the effectiveness of erythrocytapheresis against phlebotomy, both regarding the impact on the reduction in iron overload as well as reduction in patient "burden". A...
Detailed Description
In this project we plan to evaluate the effectiveness of erythrocytapheresis against phlebotomy, both regarding the impact on the reduction in iron overload as well as reduction in patient "burden". A...
Eligibility Criteria
Inclusion
- Hereditary haemochromatosis patients
Exclusion
- Malignancies, severe arrhythmias, congestive heart failure and/or recent angina, severe liver disease, epileptic seizures preceding in last 3 months before planned treatment
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2009
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00202436
Start Date
October 1 2004
End Date
September 1 2009
Last Update
October 20 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanquin Blood Bank Southeast Region
Maastricht, Netherlands, 6229 GR